Patent application number | Description | Published |
20080255144 | Acylated Piperidines as Glycine Transporter Inhibitors - The invention provides a compound of formula (I) or a salt or solvate thereof: | 10-16-2008 |
20080287547 | Glycine Transport Inhibitors - The present invention relates to compounds of formula (I), or to salts or solvates thereof, their use in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof. | 11-20-2008 |
20090062360 | Compounds Which Inhibit the Glycine Transporter and Uses Thereof - Compounds of formula (I) and salts and solvates thereof are provided: | 03-05-2009 |
20090270510 | GLYCINE TRANSPORT INHIBITORS - The present invention relates to compounds of formula (I), or salts or solvates thereof, their use in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof. | 10-29-2009 |
20090326027 | N-Phenyl-2-0X0-1,4-Diazaspiro [4.5] Dec-3-EN-1-YL Acetamide Derivatives And Their Use As Glycine Transporter Inhibitors - Compounds of formula (I) and salts and solvates are provided. | 12-31-2009 |
20100016374 | Compounds Which Inhibit the Glycine Transporter and Uses Thereof - Compounds of formula (I) and salts and solvates are provided: | 01-21-2010 |
20100113545 | GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS - Compounds of formula (I) or a salt thereof are provided: | 05-06-2010 |
20100216837 | GLYCINE TRANSPORT INHIBITORS - The present invention relates to compounds of formula (I), or salts or solvates thereof, their use in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof. | 08-26-2010 |